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Background: Few data exist on the functional activity of airway neutrophils in the milieu of the cystic ﬁbrosis (CF) lung. We assessed reactive
oxygen species (ROS) production by sputum neutrophils and the relationship to neutrophil viability. Identical assessments were made on
peripheral blood neutrophils from CF patients.
Methods: ROS production in sputum neutrophils was assessed in 31 CF patients at varying phases of clinical disease using ﬂow cytometry. Twenty
patients provided blood samples (including 16 who also provided a matched sputum sample). Neutrophil viability was determined using dual
annexin V (apoptosis) and propidium iodide (necrosis) staining. Comparative peripheral blood data were obtained from 7 healthy controls.
Results: ROS production was reduced in sputum compared to blood neutrophils and they demonstrated a higher level of necrosis. Subpopulations
of neutrophils with different ROS production capacity were apparent in peripheral blood. Lung function was positively associated with both the
proportion of blood neutrophils demonstrating increased ROS production and the proportion of apoptotic sputum neutrophils.
Conclusions: CF airway neutrophils display functional exhaustion. Healthier lungs in CF appear to be associated with subpopulations of blood
neutrophils with increased oxidative burst capacity and evidence for increased neutrophil apoptosis within the airway.
Crown Copyright © 2012 Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society. All rights reserved.Keywords: Cystic ﬁbrosis; Neutrophils; Oxidative stress; Respiratory burst; ROS production1. Introduction
Airway inflammation in cystic fibrosis (CF) is characterised
by profound neutrophil infiltration, which is ineffective and
fails to eradicate pathogens such as Pseudomonas aeruginosa
(P. aeruginosa). There has been speculation as to whether the
immune response is normal in CF, but the inability to clear
bacterial infection strongly suggests functional abnormalities.⁎ Corresponding author at: IronMetabolism Laboratory, The Queensland Institute
ofMedical Research, Herston Road, Herston, Brisbane, Queensland 4006, Australia.
Tel.: +61 7 3139 6394.
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http://dx.doi.org/10.1016/j.jcf.2012.11.004In healthy, non-CF individuals the mechanism for removal of
apoptotic neutrophils by macrophages following microbial
destruction is very tightly regulated [1,2]. There is evidence of
abnormal clearance of apoptotic airway neutrophils in CF with
resultant progression to secondary necrosis contributing to
ongoing inflammation and tissue damage by the release of
proteolytic enzymes [3–5]. Finally, the oxidative burst of CF
neutrophils may be exaggerated [6], which increases the risk of
oxidative damage to lung tissues even when CF patients are
clinically stable [7].
There are few studies of airway neutrophil function in adult
CF disease once chronic infection has become established and
most data have come from examination of peripheral blood. on behalf of European Cystic Fibrosis Society. All rights reserved.
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children [8,9]. In the current study, we have evaluated reactive
oxygen species (ROS) production by sputum neutrophils and
assessed the relationship to neutrophil viability in adult CF
patients with chronic infection and bronchiectasis. In addition,
we examined the oxidative burst capacity of peripheral blood
neutrophils from CF patients compared to healthy controls. The
primary outcome of interest was the relationship between the
“health” of sputum and blood neutrophils and their capacity to
generate ROS as part of the oxidative burst.
2. Methods
2.1. Subjects
We recruited 31 CF patients attending the adult CF Unit at the
Royal Hobart Hospital in Tasmania and The Prince Charles
Hospital (TPCH) in Brisbane. Patients were recruited on
admission at the time of a pulmonary exacerbation, or from the
outpatient clinic when clinically stable. Spontaneously expecto-
rated sputum was collected and processed immediately for
neutrophil functional assays. In patients recruited at the time of an
exacerbation, sputum was obtained at varying time intervals
during their hospital stay. Samples collected during the first week
of intravenous (IV) antibiotic treatment (usually within 48 h of
admission) were recorded as ‘acute’ and samples collected during
the second week of hospitalisation, when patients were clinically
improving, were designated ‘post-acute’. Stable CF patients with
no history of a recent exacerbation (within one month) were
recruited through outpatient clinics. Blood samples were also
obtained from 20 CF patients (including 16 patients who
provided a matched sputum sample, and four patients who
provided blood only). A further 11 patients provided a sputum
sample only. Seven healthy non-smoking and non-CF individuals
with no history of lung or systemic disease provided blood for
comparison (controls). Each patient provided a maximum of
one acute, post-acute or stable sample, respectively. Routine
microbiological testing of sputum identified all major pathogens
with 24 of the 31 patients chronically infected with P. aeruginosa
(see Supplementary data for full culture and antibiotic sensitivity
profiles for each patient). The Tasmanian Health and Medical
Human Research Ethics Committee and TPCH Human Research
Ethics Committee (Queensland) approved the study and written
informed consent was obtained from all patients.
2.2. Sputum processing
Sputum processing was commenced within 30 min of
collection. Saliva free plugs were selected, mixed with an
equal volume of 10% Sputolysin® (dithiothreitol, Calbiochem,
San Diego, CA, USA). A 1 ml aliquot of the homogenised
sample was used for flow cytometric (FCM) analysis of
neutrophil apoptosis and oxidative burst. A total cell count was
performed on the remainder of the sample using a Neubauer
haemocytometer. Cytospin slides were stained with Haem
Kwik (Clinipure, Wetherill Park, NSW, Australia) for the
calculation of differential cell counts.The assay sample was washed twice with PBS and passed
through a 100 μm pore nylon mesh filter. A cell count was
performed and viability determined with Trypan blue. The
sample was then resuspended in PBS to give a concentration of
approximately 1×106 cells per 100 μl assay volume. This
final cell suspension was used for both oxidative burst and
apoptosis assays. The use of FCM precluded the use of further
neutrophil isolation procedures as this method allowed us to
gate out contaminating red blood cells, mononuclear cells
and debris on the basis of size, granularity and cell surface
markers. Furthermore, examination of the cytospin prepara-
tions confirmed that neutrophils were the predominant cellular
component of the sputum samples. Because of the highly
viscoelastic nature of CF expectorated sputum and concerns
about the effect of chemical and mechanical agents on the
functionality and physical properties of neutrophils [10–13],
we conducted preliminary studies to compare the activation
status of neutrophils in CF sputum homogenised by either
Sputolysin® or mechanical disruption. The latter entailed
syringing the sample through a wide bore needle as advocated
by Hector and colleagues [11]. Consistent with the findings of
these authors, there was no significant difference in ROS
production between the different processing methods. Sim-
ilarly our experiments indicated that there was no difference in
the rates of apoptosis depending on homogenisation method
used.2.3. Isolation of peripheral blood neutrophils
Venous blood was collected and placed in lithium heparin
coated tubes. Neutrophils were isolated from whole blood
utilising a one-step double Histopaque® (Sigma-Aldrich,
Sydney, Australia) gradient technique allowing their separa-
tion from the erythrocyte and mononuclear cells. Three
milliliter of Histopaque®-1077 was layered over an equal
volume of Histopaque®-1119 followed by 6 ml of whole blood
as per product insert. Neutrophils banding at the interface of
the two Histopaque® layers were washed in PBS and a cell
count performed. Viability of the neutrophils was assessed
using Trypan blue and the cell concentration adjusted to
approximately 1×106 cells per 100 μl assay volume. This
final cell suspension was used for both apoptosis and oxidative
burst assays. Mononuclear cells were aspirated from the
Histopaque®/plasma interface layer for cryopreservation and
later studies. The need for concurrent retrieval and storage of
lymphocytes precluded the use of whole blood for neutrophil
analysis by FCM [14]. Red cell lysis in whole blood using an
ammonium chloride solution was trialled and found to
markedly increase the level of neutrophil apoptosis (data not
shown). Extreme care was undertaken to prevent artificial
activation of neutrophils, including minimising centrifugation
and washing steps, gentle pipetting and avoiding temperature
fluctuations. Whilst erythrocyte contamination was nominal
using the double Histopaque® gradient, remaining red blood
cells and cell debris were largely excluded from the FCM
analysis by adjusting the forward light scatter threshold.
Table 1
Subject demographics.
CF blood a
n=20
CF sputum a
n=31
Healthy controls
n=7
Age, years 23.5 (18–54) 26.0 (18–54) 38 (27–57)
Female/male 7/13 10/19 4/3
FEV1, litres
b 1.58 (0.59–3.98) 1.78 (0.59–4.46) N/A
FEV1 % predicted 67 (21–104) 51 (21–104) N/A
Data are presented as median and (range). N/A — not available.
a Sixteen of these patients appear in each column, i.e., matched blood and
sputum samples.
b Best lung function achieved over past six months when clinically stable.
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Cell suspensions were resuspended in the binding buffer
supplied with the Annexin V-FITC Apoptosis Kit 1 (BD
Pharmingen, North Ryde, NSW, Australia). Cells were labelled
with annexin V-FITC (AV) and propidium iodide (PI), and
incubated in the dark at room temperature for 15 min. 400 μl of
binding buffer was added to each tube and the samples analysed
by flow cytometry within an hour. Separate control tubes
containing cells exposed to PBS (unstained), AV and PI only
were also included. Representative flow cytometry images for
apoptosis and necrosis are provided in the Supplementary files.
2.5. Oxidative burst assessment
To determine ROS production using flow cytometry, neutro-
phils were labelledwith hydroethidine (HE; Invitrogen,Mulgrave,
VIC, Australia) and 2′,7′-dichlorodihydrofluorescein diacetate
(DCFH-DA; Invitrogen). We studied neutrophil ROS generation
using both single and dual staining methods [15,16]. The probes
are introduced into the cells in a non-fluorescent form, which then
become oxidised to their fluorescent derivatives, ethidium (E) and
2′,7′-dichlorofluorescein (DCF). The redox state of the cells can
then be measured by an increase in the fluorescence of the
oxidised probe when it is excited at a wavelength specific to its
fluorochrome. HE and DCFH-DA are considered to be relatively
specific for superoxide radicals and hydrogen peroxide respec-
tively [17–19]. The oxidative burst was initiated ex vivo by the
addition of phorbol 12-myristate 13-acetate (PMA; Calbiochem,
Merck, Kilsyth, VIC, Australia), which stimulates NADPH
oxidase directly to produce superoxide anions. These radicals
rapidly dismutate to hydrogen peroxide either spontaneously or
catalysed by superoxide dismutase [20]. The fluorescence of the
oxidised products, DCF and E, is proportional to the intensity of
the oxidative burst. As a proof of concept, we chose to stimulate
neutrophils with PMA, which represents a supra-physiological
stimulus because we considered it likely that sputum neutrophils
would not respond to physiological stimuli such as interleukin
(IL)-8 as a consequence of receptor cleavage (see the Discussion
section).
2.6. Measurement of ROS using DCFH-DA and HE
Working solutions of dyes and reagents were prepared
immediately prior to commencing the assay, kept on ice and
protected from light. DCFH-DA was dissolved in 100% ethanol
(1 mg/ml) and appropriately diluted with PBS to produce the
final optimised working concentration (5–10 μM). HE was
reconstituted in dimethyl sulphoxide (DMSO) and once again
diluted with PBS to produce the final working solution
(5–10 μM). Neutrophils were loaded with DCFH-DA or HE
in a 37 °C water bath in the dark for 15 min and 5 min
respectively [21]. One tube containing both dyes and an
unstained control tube (PBS only) were also included. The
loaded cells were split into two aliquots of 100 μl. PMA was
added at a concentration of 100 ng/ml to one aliquot and the
other was left unstimulated. All tubes were incubated for afurther 30 min, immediately placed on ice, then analysed by
FCM (FACSCanto II, Becton-Dickinson, North Ryde, NSW,
Australia). Neutrophils were gated using side scatter versus
forward scatter and identification of the neutrophil population in
sputum was verified by staining with CD11b and CD66b.
Fluorescence of the oxidised products was measured on
approximately 10,000 of the gated cells. FCM data were analysed
using BD FACS Diva software and FlowJo (TreeStar). Mean
fluorescence intensity (MFI) was calculated as geometric mean.
To correct for any potential inter-assay variation, a ratio of the
MFI of stimulated to spontaneous ROS production was used to
compute a stimulation index (SI), which is effectively a measure
of respiratory burst [9]. Similarly, a resting index (RI) was
derived from the ratio of the spontaneous to unstained
background ROS production, thereby providing an estimate of
oxidative potential of the cell (oxidative stress condition). To
maintain consistency when making comparisons between
peripheral blood and sputum FCM measurements, MFI's were
calculated on gated bright fluorescence (‘high responding’
neutrophils) in blood. The proportion of cells in this hyper-
responsive neutrophil population was recorded in all blood
samples.
2.7. Statistical analysis
SPSS version 18 (SPSS Inc, Chicago, IL, USA) was used to
analyse data using the non-parametric Mann–Whitney rank
sum test to compare medians of selected variables when
assessing airway neutrophils and blood neutrophils indepen-
dently and the Wilcoxon U signed-rank test for matched blood
and sputum samples. Correlations were computed using
Spearman's rank test. Graphs were displayed using box and
whisker plots showing medians, inter-quartile ranges, maxima
and minima. Alternatively, scatter plots were used to illustrate
variability within groups and to represent associations. p-Values
of b0.05 were considered significant in all analyses.
3. Results
The demographic data of the CF patients and healthy controls
are presented in Table 1. Healthy controls were older than
individuals with CF and more males than females with CF
provided sputum and blood samples, but there was no apparent
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no difference between neutrophil functional assays depending on
whether CF patients were chronically infected withP. aeruginosa
or not, irrespective of clinical status. None of the patients were
receiving oral corticosteroids at the time of sampling. Thirty-one
CF patients provided a total of 47 sputum samples during
different clinical phases of disease, and 20 patients provided a
total of 21 blood samples at different clinical time-points.3.1. Apoptosis and viability in CF blood neutrophils compared
to normal controls
Peripheral blood neutrophils from CF patients experiencing
an acute exacerbation showed a trend toward increased viability
(A−PI−) and a lower proportion of apoptotic cells (A+PI−)
compared with normal controls (Fig. 1). This trend reached
significance at the post-acute stage (pb0.05, Fig. 1). Repre-
sentative FACS images for analysis of apoptosis and necrosis in
CF and control blood neutrophils are presented in the
Supplementary files (Suppl. Fig. 1).3.2. Apoptosis and viability in matched CF sputum and blood
neutrophils (Fig. 2)
The level of viable neutrophils (A−PI−) was significantly
reduced in sputum during exacerbations (acute and post-acute
phases), compared with matched blood counterparts. In
parallel, the proportion of necrotic cells (A+PI+) was
increased in CF sputum compared to peripheral blood samples,
particularly in the post-acute phase. There was a significant
increase in the proportion of A−PI+ neutrophils in sputum
compared to blood during exacerbations (acute and post-acute).
The number of patients with matched blood and sputum during
stable phase (n=3) was too small for a meaningful analysis to
be undertaken. Apoptosis and viability scatter plots for thisFig. 1. Apoptosis and viability in CF blood during acute (pale grey bars, n=11) and
post-acute (dark bars, n=8) stage exacerbation compared with controls (white bars,
n=7). *: p=0.037. Apoptosis is analysed by the Annexin V/Propidium iodide
assay where A+P+ labelled cells are late apoptic/necrotic; A+PI− are apoptotic
and A−PI− are viable/non-apoptotic.stable matched group have been included in the Supplementary
material (Suppl. Fig. 2).3.3. Flow cytometric analysis of ROS in matched sputum and
peripheral blood neutrophils
Flow cytometric histograms of DCFH-DA and HE fluores-
cence in sputum neutrophils were predominantly unimodal
(Fig. 3). In contrast, peripheral blood neutrophils displayed a
more complex, primarily bi-modal distribution of DCFH-DA and
HE fluorescence, with distinct populations of ‘low’ and ‘high’
responding neutrophils (Fig. 4). Occasionally a multi-modal
pattern was apparent and several different neutrophil sub-
populations could be identified. The production of ROS by
neutrophils in matched CF sputum and blood samples compared
to healthy controls is summarised in Table 2. Data from all
sputum and blood samples available for analysis, i.e., matched
and unmatched are shown in Table 3. Blood neutrophil data are
based on the gated high responding sub-population only, whereas
the sputum data are based on their unimodal distribution of
response and are therefore representative of the “whole” sputum
neutrophil population. ROS scatter plots for the stable matched
blood and sputum group have been included in the Supplemen-
tary material (Suppl. Fig. 3).
There was a trend toward reduced ROS production in “resting”
(PMA-unstimulated) sputum neutrophils (RIHE and RIDCF)
compared to their matched blood counterparts during exacerba-
tions (acute and post-acute phases, Table 2), especially with
respect to RIDCF. However, the capacity of sputum neutrophils to
generate further ROS on PMA activation (SIHE and SIDCF) was
significantly reduced compared to blood neutrophils.3.4. ROS in CF blood neutrophils compared to normal
controls (Table 3a)
Unstimulated HE fluorescence (RIHE) was similar in CF and
control blood neutrophils. In contrast, HE fluorescence in
PMA-stimulated neutrophils (SIHE) was significantly reduced
in CF compared to normal controls, although the difference was
small. These differences held true whether acute or post-acute
CF neutrophils were examined. When DCF fluorescence was
examined, unstimulated and PMA-stimulated CF blood neu-
trophils in the acute patients demonstrated a trend towards
increased DCF fluorescence (RIDCF and SIDCF) compared with
healthy controls, which almost reached significance in acute CF
patients (p=0.06). The extent and nature of these differences
(in RIDCF and SIDCF) between the CF patients and controls
were largely dependent on whether single or dual staining was
employed (see below). Overall, the response of post-acute CF
neutrophils when compared with acute phase accentuated the
differences with respect to controls when RIDCF and SIDCF
were evaluated with dual staining.
There was a high degree of variability in measured HE and
DCF fluorescence levels in CF patient blood neutrophils at all
clinical time points contrasting with a much narrower range of
values in healthy controls.
Fig. 2. Influence of clinical status on apoptosis and viability in CF airway neutrophils (pale grey bars) compared to matched blood (dark bars) samples. a) Acute stage
exacerbation, n=8; *: p=0.017; †: p=0.036; b) Post-acute stage, n=7; ‡: p=0.028; §: p=0.046; ¶: p=0.046.
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Analysis of sputum samples depending on clinical status
revealed a higher SIHE during acute compared to post-acute
phases (p=0.03) with a similar trend for SIDCF (p=0.05). Both
SIHE and SIDCF were significantly higher in sputum neutrophils
obtained from clinically stable patients compared to post-acute
samples. SIHE and SIDCF fluorescence in clinically stable patients
did not vary from acute phase. However, when matched acute
and post-acute sputum samples from the same patient were
compared these differences whilst still evident, were not so
marked (Table 2). Similarly, whilst trends were apparent for RIHE
and RIDCF, the resting fluorescence of sputum neutrophils was
not significantly affected by clinical status.
3.6. Effect of double staining on ROS production (Table 3a and b)
There was no significant change in RIHE or SIHE for blood
neutrophils in CF patients in the presence of DCFH-DA (data not
shown). Control blood neutrophils however, showed small but
significant changes in RIHE and SIHE with dual staining. There
was an increase in RIDCF but decrease in SIDCF in CF blood
neutrophils in the presence of HE. This effect of dual staining
with HE on DCF-fluorescence was not seen in healthy control
neutrophils. In contrast, in sputum neutrophils simultaneous
staining with DCFH-DA affected RIHE (during all clinical states)Fig. 3. Representative flow cytometric profiles comparing CF sputum and blood
stimulation and without PMA stimulation (baseline).but SIHE remained unaffected (data not shown). Consistent with
the findings in CF blood neutrophils, dual staining in sputum
neutrophils also increased RIDCF and decreased SIDCF fluores-
cence (see Fig. 4).
3.7. Correlations between cell viability, oxidative stress,
clinical status and lung function
Total sputum cell counts performed using light microscopy
and a haemocytometer were not related to any of the markers of
cell viability or ROS production (data not shown). RIHE
strongly correlated with the proportion of apoptotic (A+PI−)
sputum neutrophils during both exacerbations and clinical
stability (Fig. 5). There was also a strong positive relationship
between RIHE and the proportion of secondarily necrotic cells
(A+PI+) during exacerbations (Fig. 5), but there was no such
relationship in stable patients.
A strong positive association was noted between FEV1
percentage predicted (FEV1%) and the proportion of apoptotic
neutrophils in CF sputum following IV antibiotic treatment and
there was an equally strong, yet inverse, relationship between
FEV1% and the proportion of viable sputum neutrophils at the
end of treatment (Fig. 6). In contrast, there was no significant
correlation between neutrophil viability and lung function
during acute or stable clinical stages. There was also a positive
association between FEV1% and the intensity of the oxidativeneutrophil ROS production using a) HE probe and b) DCFH-DA probe with
Fig. 4. Representative flow cytometric frequency histograms of CF blood neutrophils showing bimodal population distribution with respect to (a–b) DCF
fluorescence in single staining and dual staining mode respectively and (c–d) HE fluorescence showing single staining and dual staining. Dotted lines represent
oxidation of the probes at rest and solid lines show response with PMA stimulation.
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p=0.022). Examination of the relationship between FEV1%
and the proportion of high responding neutrophils in CF bloodTable 2
ROS production in CF sputum neutrophils compared tomatched blood neutrophils
during an exacerbation.
ROS index Sample Acute
n=8
Sig. Post acute
n=8
Sig.
RIHE Blood 35.9 (26.8–46.0) 38.2 (24.3–79.0)
Sputum 26.6 (13.4–40.6) 0.30 25.1 (14.6–85.2) 0.22
SIHE Blood 6.8 (3.5–8.9) 5.9 (2.6–7.3)
Sputum 1.1 (1.1–1.3) 0.01 1.0 (0.9–1.0) 0.01
RIDCF Blood 149 (75–706) 123 (43.8–165)
Sputum 66.2 (48–117) 0.07 47.1 (41.3–61.3) 0.05
SIDCF Blood 21.0 (13.9–28.9) 19.6 (10.9–57.5)
Sputum 2.0 (1.6–3.4) 0.02 1.7 (1.4–2.3) 0.01
Data are presented as median (interquartile range); Sig. refers to the significance
between blood and sputum ROS in matched samples. ROS: reactive oxygen
species; RIHE: resting index derived from a ratio of the mean fluorescence
intensity (MFI) of spontaneous to unstained background ROS production
measured by the HE probe; SIHE: stimulation index derived from a ratio of
stimulated to spontaneous ROS production measured by the HE probe; RIDCF:
resting index measured by the DCFH-DA probe; SIDCF: stimulation index
measured by the DCFH-DA probe.samples revealed two distinct cluster relationships above and
below an FEV1 of 40% of predicted (Fig. 7).
4. Discussion
We present novel findings of sputum neutrophil functional
exhaustion compared to blood neutrophil counterparts in CF
patients. Sputum neutrophils exhibited a unimodal pattern of
oxidant burst capacity, whereas blood neutrophils demonstrated
a bimodal and occasionally multimodal distribution. Better
lung function was associated with a greater proportion of blood
neutrophils displaying increased oxidant capacity. A higher
proportion of apoptotic neutrophils in sputum during recovery
from an acute exacerbation also correlated with better lung
function.
The conventional paradigm in CF is of oxidative injury to
the airway generated by activated neutrophils, compounded by
deficient anti-oxidant and anti-protease defences [22,23].
Regulation of cell death and clearance of apoptotic neutrophils
in the CF airway may be abnormal, with apoptotic cells
proceeding to secondary necrosis with release of toxic cell
contents [24]. Our study findings support this paradigm, with
an increased proportion of necrotic neutrophils and reduced
Table 3
ROS production in (a) CF blood neutrophils and (b) CF airway neutrophils with single and double staining.
a)
Stain mode Acute n=11 Sig. Post-acute n=10 Sig. Controls n=7 Sig.
RIHE Single 37.5 (26.7–48.7) 38.2 (25.8–58.7) 40.2 (34.6–44.3)
Dual 48.2 (29.8–148) 0.40 39.8 (30.3–94.6) 0.07 42.0 (36.7–49.9) 0.03
SIHE Single 6.1 (2.8–8.2) a 5.3 (2.7–6.5) a 9.7 (8.6–10.3)
Dual 5.0 (3.9–9.5) 0.90 5.0 (2.4–6.4) a 0.05 9.0 (7.9–10.3) 0.03
RIDCF Single 87.4 (61.9–381) 85.1 (43.9–164) 66.3 (43.9–71.9)
Dual 352 (61.8–1090) b 0.09 148 (74.1–302) b 0.04 59.8 (45.9–68.6) 0.20
SIDCF Single 22.3 (12.9–29.0) 23.9 (13.3–68.0) 16.0 (12.6–25.3)
Dual 13.9 (4.6–18.4) 0.04 8.2 (5.0–15.5) b 0.01 16.1 (12.8–24.1) 0.90
b)
Stain mode Acute n=22 Sig. Post-acute n=14 Sig. Stable n=11 Sig.
RIHE Single 31.7 (15.9–66.6) 29.3 (17.5–66.8) 55.6 (32.7–61.2)
Dual 36.8 (16.9–79.3) b0.01 28.9 (17.7–73.9) 0.02 51.1 (31.8–71.3) 0.02
SIHE Single 1.3 (1.3–1.4) 1.0 (1.0–1.3) c 1.3 (1.2–1.6) d
Dual 1.2 (1.1–1.3) 0.20 1.1 (1.0–1.4) 0.33 1.3 (1.1–1.4) 0.24
RIDCF Single 72.3 (51.1–119) 57.5 (42.7–71.3) 109 (55.6–135)
Dual 133 (66.3–224) b0.01 63.0 (49.6–125) 0.06 245 (24.1–390) 0.02
SIDCF Single 3.7 (1.8–5.3) 1.7 (1.3–4.4) 4.4 (3.1–6.1) e
Dual 1.6 (1.3–2.3) 0.000 1.2 (1.0–2.2) 0.007 1.7 (1.3–2.5) 0.01
Data are presented as median (interquartile range). Single: flow cytometric measurement using one probe; Dual: flow cytometric measurement using two probes. Sig.
refers to the significance when single versus dual staining is compared.
a Signiﬁcantly different from controls at the 0.01 level.
b Signiﬁcantly different from controls at the 0.05 level.
c Signiﬁcantly different from acute stage at the 0.05 level.
d Signiﬁcantly different from post-acute at the 0.01 level.
e Signiﬁcantly different from post- acute at the 0.05 level.
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pulmonary exacerbation relative to their blood counterparts. In
contrast, the level of apoptosis in CF blood neutrophils was
lower than in control neutrophils, especially when assessed atFig. 5. Correlations between (a–c) oxidative stress (RI-HE) and apoptosis (A+PI−)
a) acute phase, r2=0.63, pb0.0001, n=18; b) post-acute phase, r2=0.73, p=0.0008,
e) post-acute, r2=0.67, p=0.003, n=11; and f) stable, r2=0.02, p=0.903, n=11.the resolution of an exacerbation. These findings are consistent
with those of McKeon et al. [25], and other studies that suggest
abnormal responses of CF blood neutrophils to pro-apoptotic
and anti-apoptotic stimuli [26]. Evidence that this mayand (d–f) oxidative stress and necrosis (A+PI+) depending on clinical status;
n=11; c) stable, r2=0.56, p=0.011, n=11; d) acute, r2=0.36, p=0.009, n=18;
Fig. 6. Correlation between a) FEV1 percentage predicted (FEV%) and apoptotic neutrophils (A+PI−) and b) FEV% and viable/non-apoptotic neutrophils (A−PI−)
during post-acute exacerbation in CF airways (n=11). a) r2=0.89, pb0.0001 and b) r2=0.68, p=0.002, respectively.
359N. Houston et al. / Journal of Cystic Fibrosis 12 (2013) 352–362represent an innate defect was proposed by Moriceau and
colleagues, after demonstration of delayed apoptosis in peripheral
blood neutrophils of CF patients and their heterozygous parents
compared with controls [27]. Reduced expression of the death
receptor TNF-R1 and increased levels of coronin-1 on CF
circulating neutrophils have been related to decreased apoptosis
[24,28]. Although we were unable to demonstrate a significant
difference between matched blood and airway neutrophil
apoptosis, Tabary et al. observed reduced spontaneous apoptosis
in blood neutrophils compared to their freshly isolated airway
counterparts [29]. Further studies on CF blood and airway
neutrophil apoptosis with larger sample numbers and comparing
different methods of evaluation are warranted.
Increased proportions of apoptotic neutrophils in sputum
were associated with better lung function, which was most
apparent when post-acute sputum samples were examined,
whereas high proportions of viable neutrophils in sputum were
associated with more severe lung function impairment. TheseFig. 7. Correlation of FEV1 percent predicted (FEV%) with proportion of high respo
the HE probe (% HE rest). ds: denotes double staining; a) r2=0.66; p=0.006; n=10; b)
n=8. Insets show excluded low FEV1% cluster (n=9).novel observations suggest that normal apoptosis and the clearance
of senescent neutrophils may be particularly important during the
resolution phase of pulmonary exacerbations in CF. The negative
correlation between lung function and viable (non-apoptotic)
neutrophils corroborates the findings of Tirouvanziam et al.,
strengthening the argument that viable cells, through their
modified functional responses, are impacting adversely on the
health of the lungs [30].
Frequent exacerbations accelerate lung function decline in
CF and patients whose neutrophils have the ability to progress
through normal apoptosis with prevention of the release of
toxic cell contents may have a survival advantage, but the
underlying cause of this difference in apoptosis capacity
requires further investigation [31]. Indeed, there are very few
published data in any infection setting on the factors that
influence neutrophil apoptosis or other functional properties
such as the oxidative burst capacity during transmigration into
tissues [32,33]. Further endorsement that CF neutrophilsnding cells producing ROS at rest using the DCFH-DA probe (% DCF rest) and
r2=0.41; p=0.096; n=8; c) r2=0.53; p=0.020; n=10; and d) r2=0.62; p=0.028;
360 N. Houston et al. / Journal of Cystic Fibrosis 12 (2013) 352–362undergo radical changes as they migrate from the blood to the
airways comes from the discovery of highly modified surface
immune-regulatory receptors and intracellular phospho-epitopes
[30]. Activation of metabolic and stress pathways occurs at the
point of airway entry potentiating the release of a range of
pro-inflammatory effector molecules [34]. Furthermore, the high
levels of IL-6 and IL-8 associated with enhanced neutrophil–
epithelial cell adhesion in the CF airways may play a role in the
persistence and augmentation of inflammation [29].
The high proportion of “purely necrotic” (A−PI+) neutro-
phils in CF sputa is difficult to explain as PI staining depends
on cell membrane disruption, which should result in annexin V
as well as PI binding [35]. One potential explanation is that
exposed phosphatidylserine (PS), which is the ligand for
annexin is unavailable for binding because of the presence of
competing molecules such as high mobility group protein
box-1 [36–38]. Alternatively, neutrophils in CF may bypass the
apoptosis pathway and proceed directly to a necrotic death
[39–42]. Furthermore, a form of neutrophil death involving
NETosis (neutrophil extracellular trap formation) has been
described, which involves neither apoptosis nor necrosis
[43–47]. These released ‘traps’ consist of DNA interspersed
with components of disintegrated phagosomes. In this study,
we did not proceed to characterise the A−PI+ neutrophil
population further, but theoretically these cells could represent
the neutrophil population undergoing NETosis. We found no
difference in the proportion of viable neutrophils (A−, PI−)
depending on whether or not patients were infected with P.
aeruginosa, which contrasts with the findings of Watt and
colleagues. However, we were primarily interested in the
relationship between oxidative burst capacity and neutrophil
viability and thus we only assessed a small number of non-P.
aeruginosa infected patients. There were insufficient data for a
separate analysis depending on infection status, but research into
the oxidative burst capacity of airway and peripheral blood
neutrophils from non-P. aeruginosa infected patients would
potentially provide additional novel insights.
We observed a reasonably strong positive association between
spontaneous ROS generation within sputum neutrophils and the
proportion of apoptotic and necrotic cells. These data support an
emerging role for increased intracellular oxidative stress
triggering cell death pathways that may lead to apoptosis,
necrosis or NETosis [39,48–50].
Spontaneous and PMA-stimulated DCF fluorescence in CF
blood neutrophils was increased compared to normal controls,
but there was wide variability in the production of ROS by CF
blood neutrophils compared to controls, presumably reflecting
varying levels of priming in response to circulating factors.
Interestingly, control blood neutrophils demonstrated an in-
crease in resting and stimulated ROS production as measured
by the HE probe compared to acute and post-acute CF blood
neutrophils, which may reflect rapid conversion (and thus
depletion) of superoxide to hydrogen peroxide within CF blood
neutrophils. Alternatively, there may be an abnormal accumu-
lation of hydrogen peroxide because of reduced intracellular
levels of glutathione (GSH) and other anti-oxidants [51,52].
Recognition of imbalances in spontaneous ROS levels has ledto therapeutic drug trials aimed at augmenting the level of GSH
in systemic neutrophils. Resultant decreases in neutrophil
recruitment to the lungs and a decline in elastase activity with
such therapeutic interventions reinforces the interrelationships
between systemic redox stress, airway inflammation and lung
function in CF [53].
The ability of CF sputum neutrophils to mount a respiratory
burst in response to PMA was significantly reduced compared
to blood neutrophils, which may contribute to a reduced ability
to kill bacterial pathogens, although we did not access this
specifically. Alternatively, reduced ROS production may
simply reflect normal physiology and the fact that the majority
of sputum neutrophils had completed their primary task of
bacterial phagocytosis. A further explanation may be the
disarming of the respiratory burst response through proteolytic
cleavage of the CXCR1 receptor, a phenomenon observed in
the airways but not in peripheral blood neutrophils [6].
Normally, it is the action of IL-8 on CXCR1 that triggers the
respiratory burst. A comparative study of sputum phagocytes
from healthy individuals showed an oxidative burst not
significantly different from blood [54], which contrasts with
our findings and adds support to the conclusion that CF airway
neutrophils are dysfunctional in their respiratory burst response
compared with blood counterparts.
Interesting insights were obtained from the studies of double
staining with HE and DCF-DA. Simultaneous versus individual
use of both fluorochromes revealed substantial differences in
spontaneous oxidation of DCFH-DA (RIDCF) in CF blood and
airway neutrophils compared to healthy control neutrophils.
Conversely, there was a reduction in the stimulated oxidative
burst (SIDCF) of CF neutrophils when HE was present. These
findings suggest the involvement of different and possibly
multiple oxidative pathways in CF neutrophils that may not be
operating in healthy controls [19]. Dissecting out the cause for
these differences in future studies will provide new insights into
the highly modulated redox pathways operating in CF neutrophils.
The relationship between lung function and the proportion
of high responding neutrophils in blood was complex. There
were two different relationship clusters depending on whether
patients had an FEV1 greater or less than 40% of predicted. The
positive relationship between FEV% and the proportion of
hyper-responsive CF blood neutrophils in patients with mild–
moderate lung function impairment once again suggests a
potential survival advantage. However, in patients with an
FEV1 less than 40% of predicted the relationship with lung
function was less clear, but these neutrophils displayed high
levels of ROS production. CF patients in the final stages of lung
disease have been shown to mount an unrelenting systemic
inflammatory response that is difficult to manage [55]. The
potential role of neutrophils in this process suggests targeted
neutrophil stabilising strategies as well as anti-microbial therapy
may be of benefit.
In summary, we present novel data on functional distur-
bances of neutrophil function and viability compared to their
peripheral blood counterparts. The existence of sub-populations
of peripheral blood neutrophils with distinct oxidant ac-
tivity profiles in CF patients and the mechanisms that favour
361N. Houston et al. / Journal of Cystic Fibrosis 12 (2013) 352–362normal apoptosis within the CF airway, particularly during the
resolution phase of pulmonary exacerbations, warrant further
investigation.
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